Sign up to stay connected

Actor portrayal.

Get going with GOMEKLI (mirdametinib)

Want to know more about GOMEKLI? Looking for support to help you throughout treatment? Please answer a few questions below and we’ll help you stay connected.

Please note: You must be at least 18 years old to submit this form.

*Required fields.

*First name

Please enter your first name.

*Last name

Please enter your last name.

*Email address

Please enter your email address.

Please enter a valid email address.

Mobile phone number

Enter mobile phone number.

Invalid mobile phone number.

Which describes you best? I am...

(Choose all that apply.)

Living with NF1-PN

Caring for someone under 18 with NF1-PN

Caring for someone 18+ with NF1-PN

Looking for more information about GOMEKLI

This site is protected by reCAPTCHA, which is a Google Product. The Google Privacy Policy and Terms of Service apply to your use of reCAPTCHA.

*By providing the information requested and checking this box, I am giving SpringWorks Therapeutics permission to collect, store, and use the information that I have provided to contact me by telephone, email, or mail to provide me with information that may be of interest to me or to invite me to participate in research, educational, and marketing initiatives. Additionally, I understand that SpringWorks may use my information (1) to help improve, develop, and evaluate products, services, materials, and programs related to this health condition and/or treatment; and (2) as further described in the SpringWorks Therapeutics’ Privacy Notice. I also understand that I may opt out of marketing messages at any time by making the request at the unsubscribe link that will be provided to me in the confirmation email. I also may exercise my Privacy Rights via the Data Subject Form.^†
^†For residents of Washington and Nevada, I understand that my information may constitute consumer health data and agree that it may be shared with SpringWorks Therapeutics’ collaborators, affiliates, representatives, agents, and contractors (collectively, "SpringWorks”) for the purposes described above, subject to the SpringWorks Consumer Health Data Privacy Policy.

Please acknowledge the SpringWorks Therapeutics information usage agreement.

*By checking this box and clicking SUBMIT, I certify that I am at least 18 years old.

Please certify you are at least 18 years old.

GOMEKLI™ (mirdametinib) Alerts: Opt in to receive text messages from SpringWorks Therapeutics regarding GOMEKLI.

By entering my mobile number and checking this box, I agree to receive autodialed sales, marketing, or other text messages from SpringWorks Therapeutics regarding GOMEKLI™ (mirdametinib) treatment and available resources. Message frequency varies. Text HELP to 59272 for help, STOP to 59272 to end. Message and data rates may apply. I understand that I am not required to opt in as a condition of purchasing any property, goods, or services. Click to view Mobile Terms & Conditions, Terms of Use, and Privacy Policy.

Please acknowledge the mobile terms and conditions.

Please complete all required fields.

NF1-PN=neurofibromatosis type 1 with plexiform neurofibromas.

What is GOMEKLI?

GOMEKLI (mirdametinib) is a prescription medicine used to treat adults and children 2 years of age and older with neurofibromatosis type 1 (NF1) who have plexiform neurofibromas that cause symptoms and cannot be completely removed by surgery.

It is not known if GOMEKLI is safe and effective in children under 2 years of age.

Important Safety Information

Before taking GOMEKLI, tell your healthcare provider about all of your medical conditions, including if you:

Have eye problems
Have heart problems
Are pregnant or plan to become pregnant. GOMEKLI can harm your unborn baby
Females who are able to become pregnant:
- Your healthcare provider should check to see if you are pregnant before you begin treatment with GOMEKLI.
- Use effective birth control (contraception) during treatment with GOMEKLI and for 6 weeks after your last dose.
- Tell your healthcare provider right away if you become pregnant or think you may be pregnant during treatment with GOMEKLI.
Males with female partners who are able to become pregnant:
- Use effective birth control (contraception) during treatment with GOMEKLI and for 3 months after your last dose.
- Tell your healthcare provider right away if your female partner becomes pregnant or thinks she may be pregnant during treatment with GOMEKLI.
Are breastfeeding or plan to breastfeed. It is not known if GOMEKLI passes into your breast milk.
- Do not breastfeed during treatment with GOMEKLI and for 1 week after your last dose.
- Talk to your healthcare provider about the best way to feed your baby during this time.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

How should I take GOMEKLI?

Take GOMEKLI exactly as your healthcare provider tells you to take it. Your healthcare provider may change your dose, temporarily stop, or permanently stop treatment with GOMEKLI if you develop certain side effects.
Take GOMEKLI twice a day, about 12 hours apart, for 21 days, followed by 7 days off treatment, to complete a 28-day treatment cycle. Your healthcare provider will decide how many treatment cycles are right for you.
Take GOMEKLI with or without food.
GOMEKLI comes in two different dosage forms, GOMEKLI capsules and GOMEKLI tablets for oral suspension. Your healthcare provider will decide the dosage form and dose of GOMEKLI that is right for you.
If you take GOMEKLI capsules: Swallow each capsule whole with drinking water. If more than 1 capsule is required, swallow 1 capsule at a time. Do not open, break or chew the capsules.
If you take GOMEKLI tablets for oral suspension, either:
- Swallow each tablet for oral suspension whole with drinking water. If more than 1 tablet is required, swallow 1 tablet at a time.
- Disperse the tablets for oral suspension in drinking water to make a liquid (suspension) before you take or give GOMEKLI.
See the “Instructions for Use” that come with your medicine for instructions on how to prepare and take GOMEKLI tablets for oral suspension.
If you miss a dose of GOMEKLI, skip the missed dose and take your next dose at your regularly scheduled time.
If you vomit at any time after taking GOMEKLI, do not take an additional dose. Take your next dose at your regularly scheduled time.

What are the possible side effects of GOMEKLI?

GOMEKLI may cause serious side effects, including:

Eye problems. GOMEKLI may cause eye problems that can lead to blindness. Your healthcare provider will check your vision before and during treatment with GOMEKLI. Tell your healthcare provider right away if you get any of the following signs or symptoms of eye problems:
- Blurred vision
- Loss of vision
- Other changes to your vision
Heart problems. GOMEKLI may lower the amount of blood pumped by your heart, which is common in children during treatment with GOMEKLI and can also be severe. Your healthcare provider will do tests before you start GOMEKLI treatment, every 3 months during your first year of treatment, and then as needed to make sure your heart is working properly. Tell your healthcare provider right away if you get any of the following signs or symptoms of heart problems:
- Coughing or wheezing
- Shortness of breath
- Swelling of your ankles and feet
- Tiredness
- Increased heart rate
Skin problems. Skin rashes are common with GOMEKLI in both adults and children and can also be severe. GOMEKLI can also cause hair loss (alopecia). Tell your healthcare provider if you develop any of the following signs or symptoms of skin problems:
- Flat skin rash
- Raised bumps on the skin
- Skin bumps that look like acne
- Skin redness
- Itchy rash
- Peeling skin

The most common side effects of GOMEKLI in adults include:

Diarrhea
Nausea
Muscle, joint, and bone pain
Vomiting
Tiredness

The most common severe abnormal blood tests in adults include an increased enzyme called creatine phosphokinase (CPK).

The most common side effects of GOMEKLI in children include:

Diarrhea
Muscle, joint, and bone pain
Stomach (abdominal) pain
Vomiting
Headache
Skin redness, swelling, or pain around the fingernails or toenails
Nausea

The most common severe abnormal blood tests in children include decreased white blood cell (neutrophil) counts and increased CPK.

GOMEKLI may cause fertility problems in females, which may affect your ability to have children. Talk to your healthcare provider if you have concerns about fertility.

These are not all of the possible side effects of GOMEKLI. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

What is GOMEKLI?

It is not known if GOMEKLI is safe and effective in children under 2 years of age.

Please click here for full Prescribing Information, including Patient Information and Instructions for Use.

Sign up to stay connected

Get going with GOMEKLI (mirdametinib)

Thank you for your request!

What is GOMEKLI?

Important Safety Information

Before taking GOMEKLI, tell your healthcare provider about all of your medical conditions, including if you:

Females who are able to become pregnant:

Males with female partners who are able to become pregnant:

How should I take GOMEKLI?

OR

What are the possible side effects of GOMEKLI?

The most common side effects of GOMEKLI in adults include:

The most common side effects of GOMEKLI in children include:

What is GOMEKLI?